Our studies are carried out in accordance with Swiss law and internationally approved guidelines. Studies are authorized by the relevant, independent Cantonal Ethics Committee and are registered with Swissmedic if necessary.
The majority of our studies are drug studies carried out on behalf of pharmaceutical companies. Clinical trials in cardiac surgery traditionally involve products from the medical technology industry, however the number of drug studies has continued to increase in recent years. For example, we are currently investigating a drug which is used to prevent blood clotting for use with the heart-lung machine.
We also follow up on our TAVI (transcatheter aortic valve implantation) patients for several years after the operation.